Gerald Watts
Watts, Gerald
VIAF ID: 210361805 (Personal)
Permalink: http://viaf.org/viaf/210361805
Preferred Forms
- 100 0 _ ‡a Gerald Watts
- 100 1 _ ‡a Watts, Gerald
-
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
Effect of fenofibrate on brachial artery flow-mediated dilatation in type 2 diabetes mellitus | |
The effect of fenofibrate on HDL cholesterol and HDL particle concentration in postmenopausal women on tibolone therapy. | |
The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients. | |
Effect of laparoscopic sleeve gastrectomy on elevated C-reactive protein and atherogenic dyslipidemia in morbidly obese patients | |
The effect of metformin and rosiglitazone on postprandial lipid metabolism in obese insulin-resistant subjects. | |
Effect of niacin on triglyceride-rich lipoprotein apolipoprotein B-48 kinetics in statin-treated patients with type 2 diabetes. | |
Effect of Statin Therapy on Arterial Wall Inflammation Based on 18F-FDG PET/CT: A Systematic Review and Meta-Analysis of Interventional Studies | |
Effect of weight loss on LDL and HDL kinetics in the metabolic syndrome: associations with changes in plasma retinol-binding protein-4 and adiponectin levels. | |
Effect of weight loss on postprandial lipemia and low-density lipoprotein receptor binding in overweight men. | |
Effect of ω-3 fatty acid ethyl esters on apolipoprotein B-48 kinetics in obese subjects on a weight-loss diet: a new tracer kinetic study in the postprandial state. | |
Effects of alcohol intake on endothelial function in men: a randomized controlled trial | |
Effects of atorvastatin and n-3 fatty acid supplementation on VLDL apolipoprotein C-III kinetics in men with abdominal obesity | |
Effects of exercise and fat ingestion on high density lipoprotein production by peripheral tissues. | |
Effects of exercise training on conduit and resistance vessel function in treated and untreated hypercholesterolaemic subjects. | |
The effects of [omega]3 fatty acids and coenzyme Q10 on blood pressure and heart rate in chronic kidney disease: a randomized controlled trial | |
Enterprise in transition : proceedings | |
The erectile-endothelial dysfunction nexus: new opportunities for cardiovascular risk prevention. | |
An examination of the covariability of subclinical albuminuria in insulin-dependent diabetes mellitus: implications for monitoring microalbuminuria | |
The impact of non-vitamin K antagonist oral anticoagulants (NOACs) on anticoagulation therapy in rural Australia. | |
The impact of statin therapy on plasma levels of von Willebrand factor antigen. Systematic review and meta-analysis of randomised placebo-controlled trials. | |
The Knowns and Unknowns of Contemporary Statin Therapy for Familial Hypercholesterolemia | |
The lipid profile in children prior to isotretinoin therapy: an opportunity to detect familial hypercholesterolaemia | |
Menopausal Status and Abdominal Obesity Are Significant Determinants of Hepatic Lipid Metabolism in Women | |
Mental health recovery and physical health outcomes in psychotic illness: Longitudinal data from the Western Australian survey of high impact psychosis catchments | |
The metabolic and pharmacologic bases for treating atherogenic dyslipidaemia | |
A new approach to the diagnosis and treatment of atherosclerosis: the era of the liposome | |
A new electronic screening tool for identifying risk of familial hypercholesterolaemia in general practice. | |
A new model of care for familial hypercholesterolaemia: what is the role of cardiology? | |
A novel missense SMPD1 gene mutation, T460P, and clinical findings in a patient with Niemann-Pick disease type B presenting to a lipid disorders clinic | |
An online questionnaire survey of UK general practitioners’ knowledge and management of familial hypercholesterolaemia | |
An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer | |
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management | |
The potential role of an expert computer system to augment the opportunistic detection of individuals with familial hypercholesterolaemia from a community laboratory. | |
A randomized trial of the effect of statin and fibrate therapy on arterial function in CKD. | |
The renaissance of lipoprotein(a): Brave new world for preventive cardiology? | |
The role of arterial elasticity and cardiovascular peripheral resistance as clinically relevant indices of health status in people with psychosis | |
The Role of Nutraceuticals in Statin Intolerant Patients | |
The Role of Sympatho-Inhibition in Combination Treatment of Obesity-Related Hypertension. | |
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction | |
The shape of things to come in lipid management: a feast of reason. | |
Synovial fibroblasts self-direct multicellular lining architecture and synthetic function in three-dimensional organ culture | |
Systematic detection of familial hypercholesterolaemia in primary health care: a community based prospective study of three methods | |
A systematic review of economic evaluations of the detection and treatment of familial hypercholesterolemia. | |
Thematic review series: patient-oriented research. Design and analysis of lipoprotein tracer kinetics studies in humans. | |
Therapeutic regulation of apoB100 metabolism in insulin resistance in vivo. | |
Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus. | |
Thought for food: Clinical evidence for the dietary prevention strategy in cardiovascular disease | |
Through the ophthalmoscope: new insight into the risk of cardiovascular disease in sleep disordered breathing? | |
Tibolone decreases Lipoprotein(a) levels in postmenopausal women: A systematic review and meta-analysis of 12 studies with 1009 patients | |
To test, or not to test: that is the question for the future of lipoprotein(a) | |
Toward an international consensus-Integrating lipoprotein apheresis and new lipid-lowering drugs | |
Translational Research for Improving the Care of Familial Hypercholesterolemia: The "Ten Countries Study" and Beyond | |
Treating low HDL-cholesterol in normocholesterolaemic patients with coronary disease: statins, fibrates or horses for courses? | |
The trials and tribulations of the treatment of nonalcoholic fatty-liver disease. | |
Triglyceride-rich lipoprotein metabolism in women: roles of apoC-II and apoC-III. | |
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management | |
Under-Recognised and Underestimated: The Cardiovascular Health Burden of Familial Hypercholesterolaemia | |
Under-Reporting of Family History of Premature Coronary Artery Disease in Patients Discharged From Coronary Care: Implications for the Detection of Familial Hypercholesterolaemia | |
Urinary albumin levels in the normal range determine arterial wall thickness in adults with Type 2 diabetes: a FIELD substudy. | |
Use of Intralipid for kinetic analysis of HDL apoC-III: evidence for a homogeneous kinetic pool of apoC-III in plasma | |
The value of counting WHO-defined cardiovascular risk factors for death and disability in a national sample of adults with psychosis | |
Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia | |
Variation in Niemann-Pick C1-like 1 gene as a determinant of apolipoprotein B-100 kinetics and response to statin therapy in centrally obese men. | |
Vascular function of the peripheral circulation in patients with nephrosis. | |
Ventricular dysfunction in early diabetic heart disease: detection, mechanisms and significance. | |
Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men | |
von Willebrand factor, a possible indicator of endothelial cell damage, decreases during long-term compliance with a lipid-lowering diet | |
Waist circumference, waist-to-hip ratio and body mass index as predictors of adipose tissue compartments in men | |
What's new on therapies for elevated lipoprotein(a) | |
Why, when and how should hypertriglyceridemia be treated in the high-risk cardiovascular patient? | |
Widening the spectrum of genetic testing in familial hypercholesterolaemia: Will it translate into better patient and population outcomes? | |
World Heart Federation Cholesterol Roadmap | |
Writing on the wall for precision medicine in the prevention of atherosclerotic cardiovascular disease | |
ω-3 Fatty Acid Ethyl Esters Diminish Postprandial Lipemia in Familial Hypercholesterolemia. |